Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $125,954 - $234,109
-996 Closed
0 $0
Q4 2021

Jan 18, 2022

SELL
$225.82 - $368.51 $2.61 Million - $4.26 Million
-11,556 Reduced 92.07%
996 $253,000
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $2.55 Million - $5.56 Million
11,483 Added 1074.18%
12,552 $4.83 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $138,873 - $251,193
1,069 New
1,069 $251,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.